FEDERATED HERMES, INC.
Position in ARWR — Arrowhead Pharmaceuticals, Inc.
CIK 1056288
PITTSBURGH, PA
Position in ARWR
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$7,284,140
+$6,399,319 QoQ
Shares Held
89,365
+533.3% QoQ
Ownership
0.063%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#112
of 497 holders
Holding Since
Mar 2020
24 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ARWR Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026FEDERATED HERMES, INC. holds $2,455,215,104 across 149 Biotechnology names. ARWR ranks #59 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
719,905 | $216,713,000 | |
| 2 | RYTM |
Rhythm Pharmaceuticals, Inc.
|
1,785,716 | $198,268,046 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
256,884 | $160,177,448 | |
| 4 | MRNA |
Moderna, Inc.
|
1,794,778 | $125,688,301 | |
| 5 | KYMR |
Kymera Therapeutics, Inc.
|
749,398 | $85,933,468 | |
| 6 | EYPT |
EyePoint, Inc.
|
5,681,052 | $81,239,042 | |
| 7 | ARGX |
Argenx SE
|
87,288 | $80,983,187 | |
| 8 | ZBIO |
Zenas BioPharma, Inc.
|
3,116,805 | $79,104,510 |
All Filings in ARWR
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $7,284,140 | 89,365 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $884,821 | 14,112 | Shares | Defined | 2026-05-11 | |
| 2025-12-31 | $44,879 | 676 | Shares | Defined | 2026-02-12 | |
| 2025-09-30 | $52,010 | 1,508 | Shares | Defined | 2025-11-03 | |
| 2024-12-31 | $91,650 | 4,875 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $109,963 | 5,677 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $187,153 | 7,201 | Shares | Defined | 2024-08-08 | |
| 2024-03-31 | $421,506 | 14,738 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $227,358 | 7,430 | Shares | Defined | 2024-01-31 | |
| 2023-09-30 | $243,254 | 9,053 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $377,853 | 10,596 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $242,341 | 9,541 | Shares | Defined | 2023-05-08 | |
| 2022-12-31 | $473,294 | 11,669 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $596,321 | 18,043 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $474,207 | 13,468 | Shares | Defined | 2022-09-16 | |
| 2022-03-31 | $1,053,446 | 22,906 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $1,274,087 | 19,217 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $1,410,293 | 22,590 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $6,405,878 | 77,347 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $5,008,260 | 75,528 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $4,105,821 | 53,510 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $798,289 | 18,539 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $1,512,945 | 35,030 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $5,601,748 | 194,708 | Shares | Defined | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||